Association for Molecular Pathology v. Myriad Genetics, Inc.
United States Supreme Court
133 S.Ct. 2107 (2013)
Relevant factsFree
Myriad (defendant) discovered the location of breast-cancer-related genes and patented both the isolated genes themselves and synthetically created complementary DNA (cDNA) derived from them; Dr. Ostrer (plaintiff) sought a declaration invalidating Myriad's patents.
IssueFree
Whether a naturally occurring DNA segment is patentable merely because it has been isolated.